Surgical Oncology in Houston
Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.
As one of several treatments in the care of cancer, the specialty of surgical oncology, before modern medicine the only cancer treatment with a chance of success, has evolved in steps similar to medical oncology (pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology. Dr Murtaza Shakir specializes in the field of surgical oncology in the Houston area. He also serves the adjoining West houston cities of Katy, Texas and Richmond Texas.
The importance of trained surgeons who specialize in cancer surgery lies in evidence, supported by a number of clinical trials, that outcomes in surgical oncology are positively associated to surgeon volume—i.e., the more experiences a surgeon has in surgical oncology, the more proficient surgeon becomes, and his or her patients’ experience improved survival rates as a result. In the North American region ( US& Canada),of the surgeons trained through fellowship, surgical oncologists have among the longest training periods of any physicians/surgeons.
Our Doctor specializes in treating cancers of the Hepatobiliary tract and pancreas, as well as malignancies of the breast, stomach, colon, thyroid, parathyroid, melanomas and soft tissue sarcomas. Dr Murtaza Shakir also performs laparoscopic and robotic surgery for a variety of general surgical problems including gallbladder and hernias. Doctor is board certified in General Surgery as well as Surgical Oncology. His Surgical Oncology fellowship at University of Pittsburg Medical Center. He subsequently practiced in Louisiana, where he worked for three years as a General surgeon and a Surgical Oncologist. Dr Murtaza Shakir moved to Houston to be closer to family and friends.
Dr Shakir works hand-in-hand with anesthesiologists and pain management services to provide the premium level of care to our pre- and post-operative cancer patients.